This Cochrane Clinical Answer evaluates selective serotonin (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) versus placebo in people with social anxiety disorder.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.